Rex Remedies Limited - Company Profile

It is a healthcare public limited company based in Delhi, Delhi, India, established in 1995.
1995 Delhi, Delhi, India Active
Last Updated:
Access Report
About Rex Remedies Limited

Rex Remedies Limited, a active public limited company, was established on 02 February 1995 in Delhi, Delhi, India. Engaging in ayurvedic products & services within the manufacturing sector, it holds CIN: U74899DL1995PLC064991. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.75 Cr and a paid-up capital of ₹1.50 Cr.

Formerly known as Rex Remedies Limited, Rex (U & A ) Remedies Limited. It upholds a compliant status. Its leadership includes Hakeem Abdul Halim (Whole-Time Director), Mohd Asim (Director), Muneef Akhtar Usmani (Managing Director). Past directors included Saman Khan, Hakeem Abdul Halim, Gayoor Ali. It holds ₹13.75 Cr open charges and ₹10.19 Cr settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at A 51/1 G T Karnal Road Industrial Area, Delhi, Delhi, 110033.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74899DL1995PLC064991

  • Registration Number

    064991

  • Incorporation Date

    02 February 1995

  • Authorized Capital

    ₹1.75 Cr

  • Paid-Up Capital

    ₹1.50 Cr

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.75 Cr
  • Paid Up Capital ₹ 1.50 Cr
  • Company Age 31 Year, 1 Month
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 13.75 Cr
  • Satisfied Charges ₹ 10.19 Cr
  • Revenue Growth **** 10.06%
  • Profit Growth **** -59.23%
  • Ebitda **** 15.95%
  • Net Worth -1.66%
  • Total Assets **** 17.94%
Company report

Rex Remedies Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Rex Remedies Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Rex Remedies Limited?
Current Directors
Name Designation Appointment Date Status
Hakeem Abdul Halim Whole-Time Director 02 Feb 1995 Current
Mohd Asim Director 27 Jan 2022 Current
Muneef Akhtar Usmani Managing Director 17 Jan 2005 Current
Aarifa Director 27 Jan 2022 Current
Mohd Arif Managing Director 02 Feb 1995 Current
Mohd Anas Director 27 Jan 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 03 Sep 2008 Past
Pramod Abcsdd Director 28 Jun 2021 Past
Pramod Abcsdd Additional Director 30 Sep 2017 Past
Pramod Abcsdd Additional Director 29 Sep 2022 Past
Pramod Abcsdd Director 28 Jun 2021 Past
Pramod Abcsdd Additional Director 29 Sep 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Rex Remedies.

Rex Remedies Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.06% increase. The company also saw a substantial fall in profitability, with a 59.23% decrease in profit. The company's net worth dipped by a decrease of 1.66%.

Rex Remedies revenue growth over time
Rex Remedies profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 10.06%
*******
*******
*******
*******
Revenue from Operations
*******
 11.17%
*******
*******
*******
*******
Total Assets
*******
 17.94%
*******
*******
*******
*******
Profit or Loss
*******
 -59.23%
*******
*******
*******
*******
Net Worth
*******
 -1.66%
*******
*******
*******
*******
EBITDA
*******
 15.95%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Rex Remedies?

In 2023, Rex Remedies had a promoter holding of 58.87% and a public holding of 41.13%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹137,458,633.00

Satisfied Charges

₹101,900,000.00

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 10.04 Cr
  • Kotak Mahindra Bank Limited : 2.25 Cr
  • Hdfc Bank Limited : 1.33 Cr
  • Centurion Bank Of Punjab Limited : 0.08 Cr
  • The Federal Bank Ltd. : 0.05 Cr
Latest Charge Details
Date Lender Amount Status
17 Oct 2024 Axis Bank Limited ₹9.75 Cr Open
04 Nov 2023 Hdfc Bank Limited ₹4.00 M Open
22 Apr 2022 Hdfc Bank Limited ₹4.00 M Open
06 Apr 2022 Hdfc Bank Limited ₹4.00 M Open
24 Feb 2022 Axis Bank Limited ₹2.90 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Rex Remedies?

Unlock and access historical data on people associated with Rex Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Rex Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rex Remedies's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Rex Remedies
Recent Activity within the Organization
  • Annual General Meeting

    The activity Rex Remedies Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Rex Remedies Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.

  • Charges

    A charge with Axis Bank Limited amounted to Rs. 9.75 Cr with Charge ID 101013062 was registered on 17 Oct 2024. was recorded as a recent event.

  • Charges

    Progress on A charge registered on 19 Dec 2018 via Charge ID 100224772 with Hdfc Bank Limited was fully satisfied on 06 May 2024. was documented.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 0.40 Cr with Charge ID 100836631 was registered on 04 Nov 2023. was recorded as a recent event.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.40 Cr with Charge ID 100575661 was registered on 22 Apr 2022. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Rex Remedies Limited?

The CIN of Rex Remedies Limited is U74899DL1995PLC064991.

Where is Rex Remedies Limited headquartered?

Rex Remedies Limited is headquartered at A 51/1 G T Karnal Road Industrial Area, Delhi, Delhi, 110033.

When was Rex Remedies Limited incorporated?

Rex Remedies Limited was incorporated on 02 February 1995.

Who are the current directors of Rex Remedies Limited?

The current directors of Rex Remedies Limited are

What is the primary industry of Rex Remedies Limited?

The primary industry of Rex Remedies Limited is Manufacturing.

Is Rex Remedies Limited a listed company?

Rex Remedies Limited is unlisted.

What is the capital structure of Rex Remedies Limited?

The authorized capital of Rex Remedies Limited is ₹1.75 Cr, and the paid-up capital is ₹1.50 Cr.

What is the compliance status of Rex Remedies Limited?

The compliance status of Rex Remedies Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available